Area of research
Biomaterials · Molecular Biology
Research interest
Research interests include Nanoparticle-Based Drug Delivery, Nanoplatforms for cancer theranostics, RNA Interference and Gene Delivery, and Advanced biosensing and bioanalysis techniques.
Stemness, invasion, and immunosuppression modulation in recurrent glioblastoma using nanotherapy
Intersection of Inorganic Chemistry and Nanotechnology for the Creation of New Cancer Therapies
Brain-Accumulating Nanoparticles for Assisting Astrocytes to Reduce Human Immunodeficiency Virus and Drug Abuse-Induced Neuroinflammation and Oxidative Stress
Controlled release nanoplatforms for three commonly used chemotherapeutics
Recent advances, status, and opportunities of magneto-electric nanocarriers for biomedical applications
Metabolic Modulation of the Tumor Microenvironment Leads to Multiple Checkpoint Inhibition and Immune Cell Infiltration
Orally Administrable Therapeutic Synthetic Nanoparticle for Zika Virus
MRI-Guided, Noninvasive Delivery of Magneto-Electric Drug Nanocarriers to the Brain in a Nonhuman Primate
Nanotechnology-mediated crossing of two impermeable membranes to modulate the stars of the neurovascular unit for neuroprotection
A designer bow-tie combination therapeutic platform: An approach to resistant cancer treatment by simultaneous delivery of cytotoxic and anti-inflammatory agents and radiation
A Prodrug of Two Approved Drugs, Cisplatin and Chlorambucil, for Chemo War Against Cancer
Core hydrophobicity tuning of a self-assembled particle results in efficient lipid reduction and favorable organ distribution
Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug
Development of Therapeutic Polymeric Nanoparticles for the Resolution of Inflammation
α<sub>V</sub>β<sub>3</sub> Integrin-Targeted PLGA-PEG Nanoparticles for Enhanced Anti-tumor Efficacy of a Pt(IV) Prodrug